At nFerence Labs, the "Google of Biomedicine" (See nference.ai/media ), where we are building
the world's first large-scale computational platform for reverse engineering biology.
Just as 20th-century science comprised of the deconstruction of physics unlocking all the
engineering and tech applications we are so familiar with, this century is witnessing the
deconstruction or reverse engineering of biological systems to unlock all kinds of medical and
wellness applications. nFerence is one of the few companies with the data, funding, people, and tech
to make significant initial forays into this 21st-century endeavor.
Our platform is premised on using AI and high-performance computing to connect clinical
observations (phenotypes) to DNA-level phenomena (genotypes); in the process helps unravel
biology, as well as help pharma companies, perform faster and more efficient drug discovery, and
help early diagnosis of several key diseases.